Last updated: July 28, 2025
Introduction
The patent WO2011011060, filed under the auspices of the World Intellectual Property Organization (WIPO), pertains to an innovative pharmaceutical invention. As a patent publication, it provides insights into intellectual property (IP) strategies, technological scope, and competitive positioning within the pharmaceutical sector. This analysis dissects the patent's scope and claims, evaluates its technical landscape, and contextualizes its strategic significance within the global patent ecosystem.
Patent Overview
Publication Number: WO2011011060
Application Number: PCT/SG2009/000370
Filing Date: August 21, 2009
Publication Date: January 27, 2011
Applicants: Typically, a pharmaceutical entity or consortium (not specified here, due to lack of explicit data).
Technology Field: Likely relates to pharmaceutical compositions, drug delivery systems, or specific chemical entities, consistent with PCT filings in the WIPO system.
Scope and Claims
Claims Analysis:
The core of any patent lies in its claims, which define the legal boundaries of the inventive subject matter. While the exact wording of WO2011011060's claims is unavailable here, typical claims in this category often encompass:
- Compound Claims: Covering specific chemical entities, such as novel molecules or derivatives with therapeutic activity.
- Use Claims: Methods for treating a disease with the claimed compounds.
- Formulation Claims: Specific pharmaceutical compositions or delivery systems involving the compounds.
- Process Claims: Methods of preparing the active compounds.
In similar patents, claims are usually divided into independent and dependent categories.
- Independent claims broadly cover the novel compounds or methods without reliance on other claims.
- Dependent claims specify particular embodiments or narrower aspects, such as specific substituents or formulations.
Given the typical scope of WIPO patents in pharma, WO2011011060 likely claims:
- A novel chemical compound with a particular structure (e.g., a unique heterocycle, stereochemistry, or substituents).
- Its use in treating specific conditions (e.g., cancer, neurological disorders, infectious diseases).
- Pharmaceutical compositions comprising the compound.
- Methods of manufacturing the compound or compositions.
Scope of the Patent:
The scope depends on claim breadth:
- Broad Claims: If the patent claims a general chemical scaffold with various substituents, it potentially covers a wide chemical space and multiple therapeutic indications.
- Narrower Claims: Specific sub-structures or particular isomers with demonstrated efficacy.
Analysis of patent strategies indicates that broad claims, while offering extensive protection, may risk closer scrutiny or invalidation if prior art exists. Narrow claims provide more defensibility but less market exclusivity.
Technological and Patent Landscape
Chemical Space and Innovation
The patent landscape in pharmaceutical chemistry is highly competitive, often characterized by overlapping claims, dense prior art, and rapid innovation cycles. For WO2011011060, the core innovation likely revolves around:
- A novel chemical entity exhibiting improved efficacy, bioavailability, or safety.
- A new therapeutic application for known compounds.
- An inventive formulation or delivery mechanism.
The patent landscape surrounding such innovations may include:
- Existing patents on similar chemical classes (e.g., kinase inhibitors, opioids, antiviral agents).
- Related patents in the same therapeutic area, possibly overlapping with WO2011011060’s claims.
- Prior art disclosures from academic and industrial entities.
Competitive Positioning
The patent grants a territorial scope via national phase filings—once granted, it provides exclusivity in jurisdictions recognizing it. The patent’s strategic value depends on:
- The breadth of claims and their enforceability.
- The strength of the prior art landscape.
- The patent family’s geographical coverage, including key markets like the US, EU, China, Japan, and emerging markets.
Legal Status and Lifecycle Considerations
Since the publication date is 2011, the patent’s status depends on jurisdiction-specific procedures. If maintained, expiry is expected around 20 years from filing, i.e., circa 2029.
Patent maintenance fees and potential challenges (e.g., oppositions, invalidation actions) influence core strategic decisions.
Strategic Implications
- Freedom-to-operate (FTO): Analyzing this patent’s claims is essential for competitors to assess infringement risks, especially if the claims are broad.
- Milestone for R&D: The patent’s scope delineates the technological boundary of the innovation space, guiding further research.
- Licensing and Partnerships: Broad or strong claims attract licensing opportunities, especially if the invention addresses significant unmet medical needs.
Conclusion and Key Takeaways
- Scope of WO2011011060 likely encompasses a novel chemical compound with therapeutic application, possibly coupled with formulations or methods of treatment.
- The claims’ breadth plays a crucial role in determining the patent’s strength and commercial leverage.
- The patent landscape in this space suggests high competition, with overlapping patents potentially challenging enforceability.
- Strategic positioning hinges on claim robustness, geographical coverage, and ongoing patent prosecution or legal challenges.
Key Takeaways
- Robust Claim Drafting is Critical: Broad claims enhance market protection but risk invalidation; narrower claims offer defensibility.
- Patent Landscape Vigilance: Continuous monitoring of prior art and related patents ensures competitive intelligence and risk mitigation.
- Strategic Jurisdiction Filing: Prioritization of filings in high-value markets maximizes patent value.
- Alignment with R&D: Patents should correlate with clinical development milestones and therapeutic focus areas.
- Lifecycle Management: Proactive strategies, including patent extensions and challenges, sustain competitive advantage.
FAQs
-
What is the typical scope of claims in pharmaceutical patents like WO2011011060?
They often cover novel chemical compounds, their uses, formulations, and methods of manufacture. The breadth varies depending on strategic considerations.
-
How does the patent landscape influence the strength of WO2011011060?
Overlapping patents and prior art can limit enforceability, especially if claims are broad. Strategic prosecution and claim amendments help navigate this landscape.
-
Can WO2011011060’s claims be challenged legally?
Yes. Competitors or third parties can file for patent oppositions or invalidation procedures if prior art or other grounds are identified.
-
What role does WO2011011060 play in the patent pipeline of a pharmaceutical company?
It serves as a foundation for exclusivity, licensing revenue, and a barrier to entry for competitors within its scope.
-
How can companies maximize the value of this patent?
By securing broad jurisdictional coverage, maintaining patent integrity through effective prosecution, and leveraging it for partnerships or market exclusivity.
References
[1] WIPO Patent Publication WO2011011060, 2011.
[2] World Intellectual Property Organization, Patent Cooperation Treaty (PCT) statistics, 2011.
[3] OECD, “Patent Statistics,” 2020.
[4] European Patent Office, Patent Landscaping Reports, 2021.
[5] Patent Scope Database, WIPO, 2023.
(Note: Specific claims language and detailed legal status are not accessible without the full text of the patent document. This analysis synthesizes typical features based on patent norms and the available bibliographic data.)
